Advances in treatment, notably nutritional supplementation with odd-carbon medium-chain triglycerides, have improved the quality of life of persons with long-chain fatty acid oxidation disorders (LC-FAODs). However, the complexity and multisystem impact of these rare metabolic conditions requires a large, interprofessional, multidisciplinary care team to coordinate care over the lifespan. In addition to highlighting key concepts in patient management, this activity provides an overview of the principles of interprofessional collaboration and describes recommended roles for each member of the interprofessional care team.
Course Credit:
0.25 AAPA Category I CME Credit
0.25 ACPE Contact Hours
0.25 AMA PRA Category 1 CreditsTM
0.25 ANCC Contact Hours
0.25 CA-BRN Contact Hours
Dates:
Opens: 2025-11-14
Closes: 2026-11-14
Target Audience:
Dietitians, nurse practitioners, pharmacists, physician associates, and physicians who provide care to patients with long-chain fatty acid oxidation disorders.
This activity was self-funded by Annenberg Center for Health Sciences.
Accreditation
The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 0.25 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 ANCC contact hours.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Additional Content Planners
Vamsi Ahobila, MD (Medical Writer)No significant relationships to disclose.
Melissa Ketchum, CHCP (Planner)
No significant relationships to disclose.
Gregory Scott, PharmD, RPh (Planner)
No significant relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
-
Christopher Flores, MD
Family Medicine Physician
Eisenhower Medical Center
Rancho Mirage, California -
LaTosha Mollette, DNP
Family Nurse Practitioner
Louisiana Family Medicine Clinic
Jonesboro, Louisiana -
Michael Smith, PharmD
Clinical Pharmacist in Pain/Palliative Care
University of Michigan
Ann Arbor, Michigan -
Sandra Carol van Calcar, PhD, RD, LD
Associate Professor of Molecular and Medical Genetics
School of Medicine
Oregon Health and Science University
Portland, Oregon -
Jerry Vockley, MD, PhD
University of Pittsburgh
Cleveland Family Endowed Chair in Pediatric Research
Professor of Human Genetics
UPMC Children's Hospital of Pittsburgh
Chief of Genetic and Genomic Medicine
Director of the Center for Rare Disease Therapy
Pittsburgh, Pennsylvania
Contributing Faculty
Learning Objectives
- Describe the evolution in the treatment landscape for patients with long-chain fatty acid oxidation disorders.
- Identify strategies to improve interprofessional care of patients with long-chain fatty acid oxidation disorders.
Faculty Disclosures
Christopher Flores, MD
No relationships to disclose.LaTosha Mollette, DNP
No relationships to disclose.Michael Smith, PharmD
No relationships to disclose.Sandra Carol van Calcar, PhD, RD, LD
No relationships to disclose.Jerry Vockley, MD, PhD
Consultant: Acer, Agios Pharmaceuticals, Applied Therapeutics, Aro Biotherapeutics, BioMarin Pharmaceutical Inc., Frictionless Solutions, Horizon Therapeutics, Illumina Inc., Jaguar Gene Therapy, LogicBio Therapeutics, Orphan Labs, PTC Therapeutics, Sangamo Therapeutics, Inc., Sanofi, Satellite Bio, Society for Inherited Metabolic Disorders, WebMD Health Corp
Stock: American Gene Technologies International, Inc.